Publication | Closed Access

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial

VaccinationVaccine SafetyVaccine DevelopmentAfrican AdultsMalariaImmunologyParasite ControlPhase 1A/1bMedicineVaccine ResearchParasitologyDouble-blind Multi-centre Trial